A REALWORLD PHARMACOVIGILANCE STUDY OF FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) EVENTS FOR EMPAGLIFLOZIN AND DAPAGLIFLOZIN

被引:0
|
作者
Milutinovic, Stefan
Petrovic, Marija
Jancic, Predrag
Trajkovic, Hristina
Alarcon, Ricardo Orlando Escarcega
Chazal, Richard A.
机构
[1] Florida State Univ, Coll Med, Cape Coral, FL USA
[2] Lee Hlth Heart Inst, Ft Myers, FL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1039-07
引用
收藏
页码:319 / 319
页数:1
相关论文
共 50 条
  • [1] Pharmacovigilance Analysis Of FDA Adverse Event Reporting System (FAERS) Events For Inclisiran
    Rajak, Kripa
    Halder, Anupam
    Gautam, Seema Sharma
    Khanal, Resha
    Atrash, Anas
    Goswami, Rohan
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [2] Alpelisib-related adverse events: The FDA Adverse Event Reporting System Database (FAERS) pharmacovigilance study
    Li, Yun
    Li, Hang
    Xiang, Zhongyuan
    [J]. HELIYON, 2024, 10 (06)
  • [3] A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
    Yanchao Yin
    Yamin Shu
    Junru Zhu
    Feie Li
    Juan Li
    [J]. Scientific Reports, 12
  • [4] A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
    Guo, Menglin
    Shu, Yamin
    Chen, Guosong
    Li, Juan
    Li, Feie
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
    Yin, Yanchao
    Shu, Yamin
    Zhu, Junru
    Li, Feie
    Li, Juan
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
    Menglin Guo
    Yamin Shu
    Guosong Chen
    Juan Li
    Feie Li
    [J]. Scientific Reports, 12
  • [7] A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax
    Yang, Yang
    Shu, Yamin
    Chen, Guosong
    Yin, Yanchao
    Li, Feie
    Li, Juan
    [J]. PLOS ONE, 2022, 17 (12):
  • [8] A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib
    Zhang, Xusheng
    Ren, Xiuli
    Zhu, Tianyu
    Zheng, Wanjin
    Shen, Chengwu
    Lu, Cuicui
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [9] Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
    Zhu, Jinfeng
    Hu, Mianda
    Liang, Yingshi
    Zhong, Mingjun
    Chen, Zilin
    Wang, Zhenjie
    Yang, Yujia
    Luo, Ziyi
    Zeng, Wenqi
    Li, Jiahui
    Du, Yikuan
    Liu, Yi
    Yang, Chun
    [J]. HELIYON, 2024, 10 (14)
  • [10] Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Chengwen Teng
    Christopher R. Frei
    [J]. Drugs - Real World Outcomes, 2022, 9 : 23 - 29